Dalteparin Compared with an Oral Anticoagulant for Thromboprophylaxis in Patients with Cancer
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- October 2, 2003
has subject area
- 11 Medical and Health Sciences (FoR)
- Acenocoumarol (MeSH)
- Administration, Oral (MeSH)
- Age Factors (MeSH)
- Aged (MeSH)
- Anticoagulants (MeSH)
- Bias (MeSH)
- Dalteparin (MeSH)
- Enoxaparin (MeSH)
- General & Internal Medicine (Science Metrix)
- Hemorrhage (MeSH)
- Humans (MeSH)
- International Normalized Ratio (MeSH)
- Meta-Analysis as Topic (MeSH)
- Risk (MeSH)
- Secondary Prevention (MeSH)
- Thrombocytopenia (MeSH)
- Thromboembolism (MeSH)
- Venous Thrombosis (MeSH)
published in
- New England Journal of Medicine Journal